Back to top
more

Lantheus (LNTH)

(Delayed Data from NSDQ)

$105.55 USD

105.55
1,119,849

+1.52 (1.46%)

Updated Sep 13, 2024 04:00 PM ET

After-Market: $105.57 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Hologic (HOLX) Announces Collaboration With NFL CB Kelee Ringo

by Zacks Equity Research

Hologic (HOLX) and Eagles' CB, Kelee Ringo, come together to highlight the importance of annual mammograms and other routine health screenings.

Wall Street Analysts Believe Lantheus Holdings (LNTH) Could Rally 25.73%: Here's is How to Trade

by Zacks Equity Research

The mean of analysts' price targets for Lantheus Holdings (LNTH) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

3 Reasons Growth Investors Will Love Lantheus Holdings (LNTH)

by Zacks Equity Research

Lantheus Holdings (LNTH) possesses solid growth attributes, which could help it handily outperform the market.

Sejuti Banerjea headshot

Is It Going to Be a Soft Landing After All?

by Sejuti Banerjea

Analysts are divided on the issue, but the odds are in favor of a small and short recession.

Recent Price Trend in Lantheus Holdings (LNTH) is Your Friend, Here's Why

by Zacks Equity Research

Lantheus Holdings (LNTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Integra (IART) Builds Advanced R&D Facility in New Jersey

by Zacks Equity Research

Integra (IART) opens the Dr. Richard E. Caruso Center of Innovation and Learning in New Jersey.

Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Lantheus Holdings (LNTH). This makes it worthwhile to examine what the stock has in store.

Lantheus Holdings (LNTH) Crossed Above the 20-Day Moving Average: What That Means for Investors

by Zacks Equity Research

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Lantheus Holdings (LNTH) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 13.95% and 7.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

What Awaits Lantheus Holdings (LNTH) This Earnings Season?

by Zacks Equity Research

Lantheus Holdings' (LNTH) first-quarter results are likely to reflect solid top-line results on the back of robust product adoption.

Lantheus Holdings (LNTH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Lantheus Holdings (LNTH) closed the most recent trading day at $85.19, moving +0.35% from the previous trading session.

Illumina (ILMN) Q1 Earnings Beat Estimates, Margins Contract

by Zacks Equity Research

Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.

Lantheus Holdings, Inc. (LNTH) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Lantheus Holdings (LNTH) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Lantheus Holdings (LNTH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Lantheus Holdings (LNTH) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Lantheus Holdings (LNTH) closed at $89.61, marking a -1.02% move from the previous day.

Are Medical Stocks Lagging DexCom (DXCM) This Year?

by Zacks Equity Research

Here is how DexCom (DXCM) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.

Myriad Genetics (MYGN) Gets Permit to Expand Tumor Testing

by Zacks Equity Research

Myriad Genetics (MYGN) and Intermountain Precision Genomics receive the New York State Clinical Laboratory Permit to offer solid tumor testing to patients in all 50 U.S. states.

Zacks.com featured highlights include Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings

by Zacks Equity Research

Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings are part of the Zacks Screen of the Week article.

Vaishali Doshi headshot

4 Top-Performing Liquid Stock Picks for Robust Returns

by Vaishali Doshi

Here are four top-ranked liquid stocks, Lantheus Holdings (LNTH), Hello Group (MOMO), Turkcell Iletisim Hizmetleri (TKC) and Sea Limited (SE), which investors can add to their portfolio for solid gains

Insulet's (PODD) New Omnipod, Strategic Moves Drive Growth

by Zacks Equity Research

Insulet (PODD) has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and delivering consumer-focused innovation.

Nalak Das headshot

5 Stocks With Recent Price Strength to Maximize Your Gains

by Nalak Das

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are TGLS, CRD.B, REPX, HROW and LNTH.

Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader

by Zacks Equity Research

Abbott (ABT) receives the FDA clearance for a standalone reader to be used for the FreeStyle Libre 3 iCGM system.

Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Lantheus Holdings (LNTH) closed at $88.67 in the latest trading session, marking a +1.59% move from the prior day.

Walgreens (WBA) Declares Partnership With Prothena Corporation

by Zacks Equity Research

Walgreens (WBA) collaborates with Prothena Corporation to support patient awareness, participation and representation in a clinical trial of Prothena's Alzheimer's drug candidate, PRX012.

BRKR's Canopy Biosciences Partners With Enable Medicine

by Zacks Equity Research

BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.